Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezogabine for Depression with Anhedonia
NCT03043560Phase 2Completed
- Start
- Sep 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of retigabine in major depressive disorder (MDD), anhedonia ((none)). Started Sep 2017; status: completed.
02
Drugs
retigabine
03
Conditions
major depressive disorder (MDD)anhedonia ((none))
Beyond the preview
Go deeper on NCT03043560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03043560.